Health and Fitness Health and Fitness
Tue, May 11, 2010
[ Tue, May 11th 2010 ] - Market Wire
Rosetta Genomics to Present at the 6th Annual Rodman and Renshaw Global Healthcare Conference
[ Tue, May 11th 2010 ] - Market Wire
Corcept Therapeutics Announces First Quarter Results and Update on Development Programs
[ Tue, May 11th 2010 ] - Market Wire
American Bio Medica Corporation First Quarter 2010 Conference Call and Webcast
[ Tue, May 11th 2010 ] - Market Wire
AVI BioPharma to Present at the Rodman & Renshaw 6th Annual Global Healthcare Conference
[ Tue, May 11th 2010 ] - Market Wire
O.C. Beverages Announces Distribution for 2500 Accounts
[ Tue, May 11th 2010 ] - Market Wire
Gilead Announces $5 Billion Share Repurchase Program
[ Tue, May 11th 2010 ] - Market Wire
RXi Pharmaceuticals CEO to Present at the Rodman & Renshaw Annual Global Healthcare Conference
[ Tue, May 11th 2010 ] - Market Wire
Opexa Strengthens Tovaxin® Patent Estate Through Issuance of Key Patents
[ Tue, May 11th 2010 ] - Market Wire
CytRx to Present at the Rodman & Renshaw Annual Global Healthcare Conference in London
[ Tue, May 11th 2010 ] - Market Wire
Merck Highlights Robust Late-Stage Pipeline, Global Business Strategy and Progress of Integration
[ Tue, May 11th 2010 ] - Market Wire
Response Genetics Signs Agreement with GlaxoSmith .. e Proprietary BRAF Mutational Analysis Technology
[ Tue, May 11th 2010 ] - Market Wire
St. Jude Medical annonce le lancement europ©en d .. er systme de stimulation quadripolaire du march©
[ Tue, May 11th 2010 ] - Market Wire
St. Jude Medical annuncia il lancio europeo del p .. sistema di stimolazione quadripolare del settore
[ Tue, May 11th 2010 ] - Market Wire
St. Jude Medical gibt den europischen Marktauftri .. sten vierpoligen Herzschrittmachersystems bekannt
[ Tue, May 11th 2010 ] - Market Wire
St. Jude Medical Announces European Launch of Industrya?s First Quadripolar Pacing System
[ Tue, May 11th 2010 ] - Market Wire
Emeritus/Blackstone Joint Venture Announced as Sole Bidder in Sunwest Bankruptcy Auction
[ Tue, May 11th 2010 ] - Market Wire
Aeterna Zentaris to Present at Upcoming Rodman &; .. nual Global Investment Conference on May 18, 2010
[ Tue, May 11th 2010 ] - Market Wire
BrainStorm Announces Significant Milestones Achieved and 2009 Review
[ Tue, May 11th 2010 ] - Market Wire
Compugen Discovers Drug Target for Treatment of Multiple Myeloma
[ Tue, May 11th 2010 ] - Market Wire
Amedisys Receives Year 1 Incentive Payment from Home Health Pay for Performance Demonstration
[ Tue, May 11th 2010 ] - Market Wire
Pro-Pharmaceuticals Closes Final $570,000 Tranche From 10X Fund to Complete $6 Million Raise
[ Tue, May 11th 2010 ] - Market Wire
Wellstar International, Inc. Announces Success in Beta Test
[ Tue, May 11th 2010 ] - Market Wire
U.S. Equity News Features Micro Identification Technologies in the Fight Against Bacteria
[ Tue, May 11th 2010 ] - Market Wire
SuperGen to Present at Rodman & Renshaw Global Healthcare Conference on May 18th
Mon, May 10, 2010
[ Mon, May 10th 2010 ] - Market Wire
Forest and Almirall to Present Data from Studies .. nic Obstructive Pulmonary Disease (COPD) and LAS1
[ Mon, May 10th 2010 ] - Market Wire
Crucell Announces First Quarter 2010 Results
[ Mon, May 10th 2010 ] - Market Wire
Crucell and NIH Announce Start of Malaria Vaccine Trial in Burkina Faso
[ Mon, May 10th 2010 ] - Market Wire
Galapagos and Roche expand COPD alliance
[ Mon, May 10th 2010 ] - Market Wire
Atrium Innovations Announces First Quarter Financial Results of 2010
[ Mon, May 10th 2010 ] - Market Wire
SciClone Pharmaceuticals to Present at Two Investor Conferences in May

SciClone Pharmaceuticals to Present at Two Investor Conferences in May


Published on 2010-05-10 15:40:51 - Market Wire
  Print publication without navigation


FOSTER CITY, CA--(Marketwire - May 10, 2010) - SciClone Pharmaceuticals, Inc. (NASDAQ: [ SCLN ]) today announced that it will present at two upcoming investor conferences: Rodman & Renshaw Annual London Investment China Conference, and the Oppenheimer Annual China Dragon Call Conference. SciClone's executives will present a corporate overview and business update at each conference.

Rodman & Renshaw Annual London Investment Conference
Monday, May 17; 4:05 pm GMT
London, UK
Presenter: Friedhelm Blobel, Ph.D., President and CEO
Webcast: To access the live audio webcasts of the presentation, please log on through a link located in the Investor Relations section of SciClone's website at [ www.sciclone.com ].
Oppenheimer Annual China Dragon Call Conference
Tuesday, May 18; 4:40 pm ET
New York City, NY
Presenter: Gary Titus, Senior Vice President and CFO
Presentations made at this conference are not being webcast.

About SciClone
SciClone Pharmaceuticals (NASDAQ: [ SCLN ]) is a profit-focused, global specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. SciClone is focused on continuing international sales growth, a cost-containing clinical development strategy, and overall expense management. ZADAXIN® (thymalfasin or thymosin alpha 1) is sold in over 30 countries for the treatment of hepatitis B (HBV) and hepatitis C (HCV), certain cancers and as a vaccine adjuvant. SciClone's pipeline of drug candidates includes thymalfasin, in clinical studies as an enhancer of vaccines; SCV-07 in a phase 2 trial for the delay of onset of severe oral mucositis in patients receiving chemoradiation therapy for the treatment of cancers of the head and neck; and SCV-07 in a phase 2 trial for the treatment of HCV. SciClone has exclusive commercialization and distribution rights to DC Bead™ in China, where the product is under regulatory review. The Company also has exclusive commercialization and distribution rights to the anti-nausea drug ondansetron RapidFilm™ in China, including Hong Kong and Macau, and Vietnam, for which it will seek regulatory approval. For additional information, please visit [ www.sciclone.com ].

Contributing Sources